Labiotech's reader survey reveals what our audience wants, needs, and is interested in for 2026.
The post We asked, you answered: Labiotech’s 2026 reader survey results appeared first on
Subscribe to Labiotech.eu’s news feed.
Click on “Follow” and decide if you want to get news from Labiotech.eu via RSS, as email newsletter, via mobile or on your personal news page.
Subscription to Labiotech.eu comes without risk as you can unsubscribe instantly at any time.
You can also filter the feed to your needs via topics and keywords so that you only receive the news from Labiotech.eu which you are really interested in. Click on the blue “Filter” button below to get started.
Title: Labiotech.eu
Is this your feed? Claim it!
Labiotech's reader survey reveals what our audience wants, needs, and is interested in for 2026.
The post We asked, you answered: Labiotech’s 2026 reader survey results appeared first on
Cancer Research Horizons' CBO Tony Hickson discusses why charity and pharma need each other now more than ever.
The post How Cancer Research Horizons is building the future of childhood cancer medicine...
Discover how UCB’s pipeline strategy in 2026 is still focused on its core areas of immunology and neurology.
The post UCB’s pipeline strategy in 2026: Doubling down on immunology and neurology appeared first on
In this article, we take a look at seven clinical-stage biotechs that are fostering R&D in the Duchenne muscular dystrophy therapeutic space.
The post Seven biotechs driving progress in Duchenne muscular dystrophy a...
The CBO CEO relationship shapes biotech deal success. Discover insights from 19 industry leaders on board alignment and partnering.
The post We asked 19 biotech leaders what breaks their deals. It wasn’t the science. appeared first on